Christopher P. Austin

23.1k citations

172 papers · 11.9k indexed · 3 hit papers · h-index 59

Impact in

Computational Theory and Mathematics top 0.1%
- Computational Drug Discovery Methods
Small Animals top 0.2%
- Animal testing and alternatives

Papers in

Computational Theory and Mathematics 39
- Computational Drug Discovery Methods 39
Molecular Biology 87
- Receptor Mechanisms and Signaling 11
- Metabolomics and Mass Spectrometry Studies 11
- CRISPR and Genetic Engineering 9

Co-authors: James Inglese Anton Simeonov Ruili Huang Menghang Xia Ajit Jadhav Douglas S. Auld Wei Zheng Raymond R. Tice
Journals: Nature Reviews Drug Discovery (14 papers)Journal of Medicinal Chemistry (11 papers)SLAS DISCOVERY (8 papers)Assay and Drug Development Technologies (7 papers)Environmental Health Perspectives (6 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Christopher P. Austin

169 papers receiving 11.6k citations

Hit Papers

align trajectories log scale

Organs-on-chips: into the next decade 2020 · 611 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 Nature Reviews Drug Discovery
2013 Environmental Health Perspectives
2006 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Christopher P. Austin

Since Specialization

Citations

This map shows the geographic impact of Christopher P. Austin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher P. Austin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher P. Austin more than expected).

Fields of papers citing papers by Christopher P. Austin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher P. Austin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher P. Austin. The network helps show where Christopher P. Austin may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher P. Austin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher P. Austin Line = papers co-authored together Christopher P. Austin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Improving Patient Outcomes Using Measures to Increase Discharge Rates to Home Cureus ·Swapnil Patel, A. A. Arcidiacono, Christopher P. Austin, Steven Imburgio, Joseph Heaton, Kristin DiSandro, Divya Mathur, Rocel Besa, Ellen Angelo, Brian Walch, Mohamed Bakr, Vito Buccellato, Elliot Frank, Mohammad Hossain, Arif Asif	2024	2
2	Biological activity-based modeling identifies antiviral leads against SARS-CoV-2 Nature Biotechnology ·Ruili Huang, Miao Xu, Hu Zhu, Catherine Z. Chen, Wei Zhu, Emily M. Lee, Shihua He, Li Zhang, Jinghua Zhao, Khalida Shamim, Danielle Bougie, Wenwei Huang, Menghang Xia, Mathew D. Hall, Donald C. Lo, Anton Simeonov, Christopher P. Austin, Xiangguo Qiu, Hengli Tang, Wei Zheng	2021	34
3	The NCATS Pharmaceutical Collection: a 10-year update Drug Discovery Today ·Ruili Huang, Hu Zhu, Paul Shinn, Deborah K. Ngan, Lin Ye, Ashish Thakur, Gurmit Grewal, Tongan Zhao, Noel Southall, Mathew D. Hall, Anton Simeonov, Christopher P. Austin	2019	41
4	The NIH-Industry New Therapeutic Uses Pilot Program: Demonstrating the Power of Crowdsourcing Assay and Drug Development Technologies ·Christine M. Colvis, Christopher P. Austin	2015	4
5	The NIH-Industry New Therapeutic Uses Pilot Program: Demonstrating the Power of Crowdsourcing Christine M. Colvis, Christopher P. Austin	2015	1
6	Auranofin Induces Lethal Oxidative and Endoplasmic Reticulum Stress and Exerts Potent Preclinical Activity against Chronic Lymphocytic Leukemia Cancer Research ·Warren Fiskus, Nakhle S. Saba, Min Shen, Mondana Ghias, Jinyun Liu, Soumyasri Das Gupta, Lata Chauhan, Rekha Rao, Sumedha Gunewardena, Kevin Schorno, Christopher P. Austin, Kami J. Maddocks, John C. Byrd, Ari Melnick, Peng Huang, Adrian Wiestner, Kapil N. Bhalla	2014	198
7	The Tox21 robotic platform for the assessment of environmental chemicals – from vision to reality Drug Discovery Today ·Matias S. Attene‐Ramos, Nicole Miller, Ruili Huang, Sam Michael, Misha Itkin, Robert J. Kavlock, Christopher P. Austin, Paul Shinn, Anton Simeonov, Raymond R. Tice, Menghang Xia	2013	178
8	Chemical Genomics Profiling of Environmental Chemical Modulation of Human Nuclear Receptors Environmental Health Perspectives ·Ruili Huang, Menghang Xia, Ming-Hsuang Cho, Srilatha Sakamuru, Paul Shinn, Keith A. Houck, David J. Dix, Richard Judson, Kristine L. Witt, Robert J. Kavlock, Raymond R. Tice, Christopher P. Austin	2011	166
9	Chemical Genomic Profiling for Antimalarial Therapies, Response Signatures, and Molecular Targets Science ·Jing Yuan, Ken Cheng, Ronald L. Johnson, Ruili Huang, Sittiporn Pattaradilokrat, Anna Liu, Rajarshi Guha, David A. Fidock, James Inglese, Thomas E. Wellems, Christopher P. Austin, Xin‐zhuan Su	2011	114
10	Small-molecule agonists for the thyrotropin receptor stimulate thyroid function in human thyrocytes and mice Proceedings of the National Academy of Sciences ·Susanne Neumann, Wenwei Huang, Steve Titus, Gerd Krause, Gunnar Kleinau, Anna Teresa Alberobello, Wei Zheng, Noel Southall, James Inglese, Christopher P. Austin, Francesco S. Celi, Oksana Gavrilova, Craig J. Thomas, Bruce M. Raaka, Marvin C. Gershengorn	2009	94
11	Identification of Pregnane X Receptor Ligands Using Time-Resolved Fluorescence Resonance Energy Transfer and Quantitative High-Throughput Screening Assay and Drug Development Technologies ·Sunita J. Shukla, Ðắc-Trung Nguyễn, Ryan MacArthur, Anton Simeonov, William J. Frazee, Tina M. Hallis, Bryan D. Marks, Upinder Singh, Hildegard C. Eliason, John A. Printen, Christopher P. Austin, James Inglese, Douglas S. Auld	2009	45
12	A quantitative high-throughput screen for modulators of IL-6signaling: a model for interrogating biological networks using chemical libraries Molecular BioSystems ·Ronald L. Johnson, Ruili Huang, Ajit Jadhav, Noel Southall, Jennifer Wichterman, Ryan MacArthur, Menghang Xia, Kun Bi, John A. Printen, Christopher P. Austin, James Inglese	2009	11
13	Identification of Chemical Compounds that Induce HIF-1α Activity Toxicological Sciences ·Menghang Xia, Ruili Huang, Yi Sun, Gregg L. Semenza, Shelley Force Aldred, Kristine L. Witt, James Inglese, Raymond R. Tice, Christopher P. Austin	2009	49
14	A Dual-Fluorescence High-Throughput Cell Line System for Probing Multidrug Resistance Assay and Drug Development Technologies ·Kyle R. Brimacombe, Matthew D. Hall, Douglas S. Auld, James Inglese, Christopher P. Austin, Michael M. Gottesman, King-Leung Fung	2009	46
15	A Robotic Platform for Quantitative High-Throughput Screening Assay and Drug Development Technologies ·Sam Michael, Douglas S. Auld, Carleen Klumpp, Ajit Jadhav, Wei Zheng, Natasha Thorne, Christopher P. Austin, James Inglese, Anton Simeonov	2008	108
16	A 1,536-Well-Based Kinetic HTS Assay for Inhibitors of Schistosoma mansoni Thioredoxin Glutathione Reductase Assay and Drug Development Technologies ·Wendy Lea, Ajit Jadhav, Ganesha Rai, Ahmed A. Sayed, Cynthia L. Cass, James Inglese, David L. Williams, Christopher P. Austin, Anton Simeonov	2008	16
17	Evaluation of Micro-Parallel Liquid Chromatography as a Method for HTS-Coupled Actives Verification Assay and Drug Development Technologies ·Anton Simeonov, Adam Yasgar, Carleen Klumpp, Wei Zheng, N. Shafqat, Udo Oppermann, Christopher P. Austin, James Inglese	2007	4
18	A Cell-Based Assay for I κ B α Stabilization Using A Two-Color Dual Luciferase-Based Sensor Assay and Drug Development Technologies ·R. Eric Davis, Ya‐Qin Zhang, Noel Southall, Louis M. Staudt, Christopher P. Austin, James Inglese, Douglas S. Auld	2007	21
19	High-throughput screening assays for the identification of chemical probes Nature Chemical Biology ·James Inglese, Ronald L. Johnson, Anton Simeonov, Menghang Xia, Wei Zheng, Christopher P. Austin, Douglas S. Auld	2007	473
20	Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical libraries Proceedings of the National Academy of Sciences ·James Inglese, Douglas S. Auld, Ajit Jadhav, Ronald L. Johnson, Anton Simeonov, Adam Yasgar, Wei Zheng, Christopher P. Austin Hit paper breakdown →	2006	623

About Christopher P. Austin

Christopher P. Austin is a scholar working on Computational Theory and Mathematics, Molecular Biology, Pharmacology, Small Animals and Cancer Research, having authored 172 papers that have together received 11.9k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (39 papers), Receptor Mechanisms and Signaling (11 papers), Metabolomics and Mass Spectrometry Studies (11 papers), Pharmacogenetics and Drug Metabolism (10 papers), Biosimilars and Bioanalytical Methods (10 papers), Genomics and Rare Diseases (10 papers), Lysosomal Storage Disorders Research (10 papers) and CRISPR and Genetic Engineering (9 papers). The work is most often cited by research in Computational Theory and Mathematics (2.5k citations), Small Animals (701 citations), Molecular Biology (5.7k citations), Pharmacology (693 citations) and Biophysics (388 citations). Christopher P. Austin has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include James Inglese, Anton Simeonov, Ruili Huang, Menghang Xia, Ajit Jadhav, Douglas S. Auld, Wei Zheng, Raymond R. Tice, Noel Southall and Ronald L. Johnson. Their work appears in journals such as Nature Reviews Drug Discovery, Journal of Medicinal Chemistry, SLAS DISCOVERY, Assay and Drug Development Technologies and Environmental Health Perspectives.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact